Health
Rheumatoid arthritis drug improves outcomes in severely ill COVID-19 patients, finds new trial – News-Medical.Net
Tocilizumab, an anti-inflammatory drug used to treat rheumatoid arthritis, improves outcomes in severely ill COVID-19 patients, finds the results of a new trial…
Tocilizumab, an anti-inflammatory drug used to treat rheumatoid arthritis, improves outcomes in severely ill COVID-19 patients, finds the results of a new trial conducted in hospitals across India — one of the world’s most ethnically diverse countries. Researchers from the University of Bristol and Medanta Institute of Education and Research in India who led the study, published in The Lancet Respiratory Medicine, say it adds to existing evidence supporting the drug’s use in critically ill patients.
…
-
Noosa News13 hours agoMan charged over allegedly abandoning Arnie the German shepherd in car after claiming dog and vehicle were stolen
-
Noosa News14 hours agoMotorcyclist dies in crash with truck
-
Noosa News15 hours agoSomerville House investigating after teachers’ dossier on students leaked
-
General20 hours agoSmall-town cleaner finds himself in legal battle with EnduroShield over product packaging